Press release from PAXMAN AB’s 2019 Annual General Meeting
PAXMAN’s second AGM was held today, 23 May 2019, at NetPort in Karlshamn. Slightly more than 72 % of all issued shares were represented at the meeting. After the formal AGM, CEO Richard Paxman gave a company presentation and responded to questions from the attending shareholders.
PAXMAN publishes its interim report for Q1 2019
Steady financial improvements in combination with continued strong global growth
PAXMAN announces that bill for mandatory coverage of scalp cooling costs was rejected in Texas
PAXMAN announces that the bill, proposing mandatory insurance coverage of scalp cooling costs for cancer patients, was rejected by the Texas Senate after passing the House of Representatives. However, scalp cooling is now on the agenda in additional states, and similar bills are being prepared in New York and other states.
PAXMAN reaches milestone of 500 scalp cooling systems in the USA
PAXMAN announces that the company now has installed or signed delivery agreements for just over 500 scalp cooling systems preventing hair loss in connection with chemotherapy in the USA, only two years after receiving FDA approval. The company is now actively supporting large-scale coverage and reimbursement for the treatment.
PAXMAN publishes Annual Report for 2018
PAXMAN has now published its Annual Report for the financial year 2018.
PAXMAN announces that the state of Texas is preparing a bill proposing mandatory coverage of scalp cooling costs
PAXMAN announces that the state of Texas is preparing a bill that proposes mandatory coverage of scalp cooling costs in connection with chemotherapy by health care programs. The bill was addressed in a hearing before the House Committee on Insurance on April 16, and if it becomes legislation it would constitute an important step towards total cost coverage in the USA.
NOTICE OF THE ANNUAL GENERAL MEETING FOR PAXMAN AB
The shareholders of PAXMAN AB (publ) (”the Company”) are hereby invited to attend the Annual General Meeting on Thursday 23 May 2019 at 15:00 CET at meeting hall ”Amazonas”, NetPort, Biblioteksgatan 4, 374 35 KARLSHAMN. Registration will begin at 14:30 CET.
PAXMAN publishes newsletter on the company’s market approval in Japan
Today, PAXMAN publishes the April 2019 issue of its newsletter aimed at shareholders, investors and other interested parties.
PAXMAN receives order for 20 scalp cooling systems to Japan two weeks after market approval
PAXMAN announces that the company has received an order for 20 scalp cooling systems to Japan from its distributor Century Medical. The systems will be installed at Tokyo Medical Center Hospital and Kyoto University Hospital, with deliveries starting in June.
PAXMAN receives market approval in Japan, will initiate comprehensive marketing activities in 2019
PAXMAN announces that the company has received a market approval (Shonin) in Japan for its market leading scalp cooling system that prevents chemotherapy-induced hair loss. The approval covers all solid tumours, and the company will initiate comprehensive market activities in Japan in 2019 together with its distributor Century Medical.